http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104546789-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5649134c56edf2e7060901c6df249276 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate | 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbf66e2c79ea5d6b5f03fd33cbacd1d3 |
| publicationDate | 2015-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104546789-A |
| titleOfInvention | Medicine penetration enhancer |
| abstract | The invention discloses a medicine penetration enhancer. Oral administration is adopted, and it is known or doubted that medicines using effervescents as penetration enhancers have lower bioavailability. Effervescence can be produced in stomachs, once other dosage forms are ingested, the effervescence can be produced at other parts of gastrointestinal tracts, including but not limited to esophagi, duodenums and colons, except the stomachs with proper coatings and other technologies as another technology. Selected parts for effervescence and medicine release correspond to maximum absorption sections, displayed in the gastrointestinal tracts, of the prepared medicine, or some other treatment advantages are obtained. |
| priorityDate | 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.